Emergent Biosolutions Stock Cash And Equivalents

EBS Stock

USD 1.89 0.03 1.56%

Emergent Biosolutions fundamentals help investors to digest information that contributes to Emergent Biosolutions' financial success or failures. It also enables traders to predict the movement of Emergent Stock. The fundamental analysis module provides a way to measure Emergent Biosolutions' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Emergent Biosolutions stock.

		Last Reported	Projected for Next Year
	Cash And Equivalents	739 M	403.8 M

Cash And Equivalents is likely to drop to about 403.8 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Emergent Biosolutions Company Cash And Equivalents Analysis

Emergent Biosolutions' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Emergent Biosolutions Cash And Equivalents

642.6 M

Most of Emergent Biosolutions' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emergent Biosolutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Emergent Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Emergent Biosolutions is extremely important. It helps to project a fair market value of Emergent Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Emergent Biosolutions' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Emergent Biosolutions' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Emergent Biosolutions' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Short Term Investments	Property Plant Equipment	Deferred Long Term Liab	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.88	0.75	0.53	0.44	0.62	0.99	0.77	0.72	0.79	0.64	0.53	0.69	0.93	0.98	0.9	-0.87	0.9	0.78	0.91	0.2	0.68	0.85	-0.19	-0.6
Total Stockholder Equity	0.97		0.75	0.7	0.46	0.42	0.52	0.92	0.69	0.62	0.66	0.56	0.6	0.69	0.87	0.97	0.87	-0.82	0.92	0.76	0.91	0.09	0.66	0.83	-0.05	-0.52
Net Debt	0.88	0.75		0.64	0.5	0.48	0.7	0.93	0.7	0.76	0.89	0.7	0.28	0.59	0.91	0.83	0.81	-0.8	0.71	0.69	0.79	0.3	0.45	0.74	-0.44	-0.62
Retained Earnings	0.75	0.7	0.64		0.81	0.53	0.72	0.76	0.98	0.62	0.8	0.74	0.58	0.45	0.75	0.73	0.7	-0.78	0.77	0.55	0.71	0.22	0.75	0.73	-0.04	-0.51
Accounts Payable	0.53	0.46	0.5	0.81		0.79	0.92	0.56	0.81	0.24	0.79	0.93	0.69	0.62	0.67	0.42	0.53	-0.45	0.71	0.63	0.65	0.1	0.6	0.64	0.23	-0.05
Net Receivables	0.44	0.42	0.48	0.53	0.79		0.88	0.45	0.54	-0.06	0.72	0.85	0.69	0.77	0.64	0.34	0.48	-0.23	0.63	0.76	0.6	-0.32	0.15	0.57	0.4	0.08
Good Will	0.62	0.52	0.7	0.72	0.92	0.88		0.67	0.76	0.28	0.92	0.98	0.62	0.73	0.79	0.49	0.63	-0.46	0.72	0.76	0.72	0.03	0.42	0.69	0.1	-0.13
Total Liab	0.99	0.92	0.93	0.76	0.56	0.45	0.67		0.8	0.77	0.84	0.68	0.47	0.67	0.94	0.95	0.89	-0.87	0.85	0.77	0.88	0.26	0.66	0.84	-0.27	-0.63
Total Current Assets	0.77	0.69	0.7	0.98	0.81	0.54	0.76	0.8		0.67	0.84	0.76	0.51	0.45	0.76	0.73	0.69	-0.78	0.75	0.56	0.71	0.25	0.73	0.71	-0.14	-0.56
Short Term Debt	0.72	0.62	0.76	0.62	0.24	-0.06	0.28	0.77	0.67		0.57	0.34	-0.07	0.05	0.59	0.76	0.56	-0.88	0.5	0.19	0.57	0.62	0.63	0.47	-0.76	-0.79
Intangible Assets	0.79	0.66	0.89	0.8	0.79	0.72	0.92	0.84	0.84	0.57		0.89	0.49	0.65	0.91	0.69	0.77	-0.67	0.73	0.74	0.77	0.15	0.45	0.76	-0.16	-0.47
Common Stock	0.64	0.56	0.7	0.74	0.93	0.85	0.98	0.68	0.76	0.34	0.89		0.6	0.7	0.8	0.54	0.65	-0.55	0.79	0.72	0.78	0.12	0.51	0.7	0.06	-0.11
Current Deferred Revenue	0.53	0.6	0.28	0.58	0.69	0.69	0.62	0.47	0.51	-0.07	0.49	0.6		0.78	0.6	0.46	0.55	-0.27	0.71	0.77	0.59	-0.3	0.45	0.68	0.64	0.05
Long Term Debt	0.69	0.69	0.59	0.45	0.62	0.77	0.73	0.67	0.45	0.05	0.65	0.7	0.78		0.77	0.59	0.74	-0.35	0.76	0.98	0.72	-0.21	0.34	0.77	0.41	0.02
Short Term Investments	0.93	0.87	0.91	0.75	0.67	0.64	0.79	0.94	0.76	0.59	0.91	0.8	0.6	0.77		0.86	0.87	-0.77	0.88	0.85	0.89	0.11	0.56	0.88	-0.09	-0.49
Property Plant Equipment	0.98	0.97	0.83	0.73	0.42	0.34	0.49	0.95	0.73	0.76	0.69	0.54	0.46	0.59	0.86		0.87	-0.91	0.87	0.68	0.89	0.22	0.69	0.8	-0.24	-0.63
Deferred Long Term Liab	0.9	0.87	0.81	0.7	0.53	0.48	0.63	0.89	0.69	0.56	0.77	0.65	0.55	0.74	0.87	0.87		-0.77	0.82	0.81	0.84	0.11	0.53	0.8	-0.06	-0.46
Treasury Stock	-0.87	-0.82	-0.8	-0.78	-0.45	-0.23	-0.46	-0.87	-0.78	-0.88	-0.67	-0.55	-0.27	-0.35	-0.77	-0.91	-0.77		-0.78	-0.45	-0.8	-0.53	-0.75	-0.74	0.45	0.61
Net Tangible Assets	0.9	0.92	0.71	0.77	0.71	0.63	0.72	0.85	0.75	0.5	0.73	0.79	0.71	0.76	0.88	0.87	0.82	-0.78		0.78	0.97	0.11	0.73	0.84	0.08	-0.28
Long Term Debt Total	0.78	0.76	0.69	0.55	0.63	0.76	0.76	0.77	0.56	0.19	0.74	0.72	0.77	0.98	0.85	0.68	0.81	-0.45	0.78		0.76	-0.19	0.38	0.81	0.31	-0.17
Capital Surpluse	0.91	0.91	0.79	0.71	0.65	0.6	0.72	0.88	0.71	0.57	0.77	0.78	0.59	0.72	0.89	0.89	0.84	-0.8	0.97	0.76		0.15	0.65	0.81	-0.08	-0.33
Short Long Term Debt	0.2	0.09	0.3	0.22	0.1	-0.32	0.03	0.26	0.25	0.62	0.15	0.12	-0.3	-0.21	0.11	0.22	0.11	-0.53	0.11	-0.19	0.15		0.49	0.26	-0.67	-0.11
Cash And Equivalents	0.68	0.66	0.45	0.75	0.6	0.15	0.42	0.66	0.73	0.63	0.45	0.51	0.45	0.34	0.56	0.69	0.53	-0.75	0.73	0.38	0.65	0.49		0.61	-0.1	-0.31
Net Invested Capital	0.85	0.83	0.74	0.73	0.64	0.57	0.69	0.84	0.71	0.47	0.76	0.7	0.68	0.77	0.88	0.8	0.8	-0.74	0.84	0.81	0.81	0.26	0.61		0.05	-0.25
Net Working Capital	-0.19	-0.05	-0.44	-0.04	0.23	0.4	0.1	-0.27	-0.14	-0.76	-0.16	0.06	0.64	0.41	-0.09	-0.24	-0.06	0.45	0.08	0.31	-0.08	-0.67	-0.1	0.05		0.54
Capital Stock	-0.6	-0.52	-0.62	-0.51	-0.05	0.08	-0.13	-0.63	-0.56	-0.79	-0.47	-0.11	0.05	0.02	-0.49	-0.63	-0.46	0.61	-0.28	-0.17	-0.33	-0.11	-0.31	-0.25	0.54

Click cells to compare fundamentals

Emergent Cash And Equivalents Historical Pattern

Today, most investors in Emergent Biosolutions Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Emergent Biosolutions' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash and equivalents growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Emergent Biosolutions cash and equivalents as a starting point in their analysis.

Emergent Biosolutions Cash And Equivalents

Timeline

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict Emergent Biosolutions

Cash And Equivalents Over Time

In accordance with the recently published financial statements, Emergent Biosolutions has 642.6 M in Cash And Equivalents. This is 21.72% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 76.22% higher than that of the company.

Emergent Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emergent Biosolutions' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Emergent Biosolutions could also be used in its relative valuation, which is a method of valuing Emergent Biosolutions by comparing valuation metrics of similar companies.

Emergent Biosolutions is currently under evaluation in cash and equivalents category among related companies.

Emergent Fundamentals

	Return On Equity	-0.75
	Return On Asset	-0.048
	Profit Margin	(0.72) %
	Operating Margin	(0.18) %
	Current Valuation	866.03 M
	Shares Outstanding	52.39 M
	Shares Owned By Insiders	1.88 %
	Shares Owned By Institutions	78.65 %
	Number Of Shares Shorted	5.89 M
	Price To Earning	1.67 X
	Price To Book	0.17 X
	Price To Sales	0.10 X
	Revenue	1.12 B
	Gross Profit	290.1 M
	EBITDA	(34.4 M)
	Net Income	(223.8 M)
	Cash And Equivalents	642.6 M
	Cash Per Share	7.28 X
	Total Debt	1.41 B
	Debt To Equity	0.56 %
	Current Ratio	3.92 X
	Book Value Per Share	12.44 X
	Cash Flow From Operations	(34.1 M)
	Short Ratio	4.76 X
	Earnings Per Share	(14.85) X
	Price To Earnings To Growth	1.55 X
	Target Price	5.0
	Number Of Employees	1.6 K
	Beta	1.19
	Market Capitalization	100.59 M
	Total Asset	3.17 B
	Retained Earnings	734 M
	Working Capital	28.2 M
	Current Asset	537.41 M
	Current Liabilities	99.61 M
	Net Asset	3.17 B

About Emergent Biosolutions Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Emergent Biosolutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emergent Biosolutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emergent Biosolutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Emergent Biosolutions Investors Sentiment

The influence of Emergent Biosolutions' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Emergent. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Emergent Biosolutions' public news can be used to forecast risks associated with an investment in Emergent. The trend in average sentiment can be used to explain how an investor holding Emergent can time the market purely based on public headlines and social activities around Emergent Biosolutions. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Emergent Biosolutions' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Emergent Biosolutions' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Emergent Biosolutions' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Emergent Biosolutions.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Emergent Biosolutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Emergent Biosolutions' short interest history, or implied volatility extrapolated from Emergent Biosolutions options trading.

Pair Trading with Emergent Biosolutions

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emergent Biosolutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Emergent Biosolutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emergent Biosolutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emergent Biosolutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emergent Biosolutions to buy it.

The correlation of Emergent Biosolutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emergent Biosolutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emergent Biosolutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Emergent Biosolutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Emergent Biosolutions is a strong investment it is important to analyze Emergent Biosolutions' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Emergent Biosolutions' future performance. For an informed investment choice regarding Emergent Stock, refer to the following important reports:

How To Invest In Emergent

Details

Is Emergent Stock a good investment?

Details

What is Emergent Biosolutions' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Emergent Biosolutions Piotroski F Score and Emergent Biosolutions Altman Z Score analysis.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.

	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Share Portfolio Track or share privately all of your investments from the convenience of any device

Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.022

Earnings Share

(14.85)

Revenue Per Share

20.494

Quarterly Revenue Growth

(0.16)

Return On Assets

(0.05)

The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if Emergent Biosolutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Emergent Biosolutions Stock Cash And Equivalents

Emergent Biosolutions Company Cash And Equivalents Analysis

Cash

Bank Deposits

+

Liquidities

Current Emergent Biosolutions Cash And Equivalents

Emergent Cash And Equivalents Driver Correlations

Emergent Cash And Equivalents Historical Pattern

Emergent Cash And Equivalents Peer Comparison

Emergent Fundamentals

About Emergent Biosolutions Fundamental Analysis

Emergent Biosolutions Investors Sentiment

Pair Trading with Emergent Biosolutions

Complementary Tools for Emergent Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY